NCT01110876 2021-08-25Phase I / II Vorinostat, Erlotinib and Temozolomide for Recurrent Glioblastoma Multiforme (GBM)M.D. Anderson Cancer CenterPhase 1/2 Terminated21 enrolled 8 charts
NCT01600742 2014-01-09Vorinostat and Concurrent Whole Brain Radiotherapy for Brain MetastasisNational Taiwan University HospitalPhase 2 Terminated4 enrolled